In the article titled “Improvement of Memory by Means of Ultra-Low Doses of Antibodies to S-100B Antigen” [1], conflicts of interest should have been declared as follows. At the time of publication by OUP, the journal considered research on homeopathy, but no longer does.
Conflicts of Interest
The author Oleg Epstein is the founder and CEO of Materia Medica Holding Company and holds a relevant patent, “Curing method for pathologic syndrome and medicinal preparation” (US20030099636A1, 2003).